Johnny John - Feb 8, 2023 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
SVP CLINICAL DEV & MED AFFAIRS
Signature
/s/ Gerard Michel, Attorney-in-Fact
Stock symbol
DCTH
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 04:22 PM
Previous filing
Aug 15, 2022
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCTH Stock Option (Right to Buy) Award $0 +46.8K $0.00 46.8K Feb 8, 2023 Common Stock 46.8K $4.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 8, 2023 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions ofthe Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).